Go to menu Skip to content

Projects in progress

  • Randomized, double-blind, placebo-controlled study of the efficacy and safety of tianeptine in the treatment of COVID-19 post-COVID-19 symptoms with the study of the pathophysiology of the phenomenon using positron emission tomography, biochemical, immunological and electrophysiological parameters (COVMENT), 2021/ABM/02/00019 – 00, Principal Investigator: Prof. Anna Klimkiewicz
  • A randomized, open-label study evaluating transoral robotic surgery with adjuvant hypofractionated radiotherapy versus definitive IMRT in patients with early squamous cell carcinoma of the oropharynx, 2024/ABM/02/00042 – 01, Principal Investigator: Dr. Wojciech Solarek
  • Evaluation of the efficacy and safety of dual therapy with biologics and/or small molecules in patients with induction-resistant ulcerative colitis (RESPECT), 2022/ABM/03/00005, Principal Investigator: prof. dr hab. n. med. Maciej Gonciarz
  • Evaluation of the efficacy and safety of dual biological therapy in patients with induction-resistant Crohn's disease (FLAMING), 2022/ABM/03/00004, Principal Investigator: prof. dr hab. n. med. Maciej Gonciarz
  • Randomized trial comparing the efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA), 2022/ABM/03/00001, Principal Investigator: Joanna Kur-Zalewska, PhD
  • Changes in miRNA expression during cardiac rehabilitation after myocardial infarction FBW/05/2025, Head of the WIM-PIB Dr Aleksandra Majewska
  • Application of chemically modified MRNA molecules encoding NICD for targeted activation of the NOTCH pathway in increasing the regenerative potential of progenitor cells FBW/09/2025, Head of Research at WIM-PIB Dr. Klaudia Brodaczewska

Completed projects

  • A system for preparing, culturing, and visualizing cells in controlled O2 conditions. SPUB/SN/491340/2021, Coordinator: Dr. Klaudia Brodaczewska
  • Regulation of Serpine1 expression in renal cancer – the role of hypoxia. 2020/37/N/NZ5/04024, Head of the project: Aleksandra Majewska, M.Sc. Eng.
  • Hyperbaric oxygen therapy (HBOT) in the treatment of COVID-19 (HBOT & COVID‐19) 2020/ABM/COVID19/0043, Principal Investigator: prof. Jacek Kot